العلاج بالخلايا الجذعية

حول العلاج بالخلايا الجذعية

China hosts the world's largest portfolio of clinical-stage stem cell therapies, with over 700 active or completed clinical trials. While many of these therapies remain experimental in Western jurisdictions, qualified Chinese hospitals offer them under strict national regulatory oversight (NMPA approval and ethics committee review).

Conditions treated

• Neurological — Spinal cord injury, stroke recovery, ALS, Parkinson's, MS
• Autoimmune — Lupus (SLE), rheumatoid arthritis, Crohn's disease
• Orthopedic — Osteoarthritis (intra-articular MSC injection)
• Cardiac — Post-MI cardiac repair
• Anti-aging / wellness — IV MSC infusion (cosmetic only, not medical claim)

Cell types available

• Umbilical cord-derived mesenchymal stem cells (UC-MSC) — most common
• Bone marrow-derived MSCs
• Adipose-derived MSCs
• Induced pluripotent stem cells (iPSC) — research only

⚠️ Important: Stem cell therapy effectiveness varies significantly by condition. We provide honest expectations: clear evidence for some indications, exploratory for others. We will share peer-reviewed research relevant to your case before you commit.